This work, Lung Cancer, Volume 2: Diagnostic and Therapeutic Methods and Reviews, in the Methods in Molecular Medicine series presents an overview of the current status of those methods useful in the diagnosis and tre- ment of lung cancer-both as it exists in the clinic and as it is being revoluti- ized in the laboratory. The book is intended to serve as a resource for researchers wishing to increase their knowledge of current and cutting edge technologies, in order that their investigations into neoplasms of the lung may benefit from this enriched diversity of techniques and approaches. Owing…mehr
This work, Lung Cancer, Volume 2: Diagnostic and Therapeutic Methods and Reviews, in the Methods in Molecular Medicine series presents an overview of the current status of those methods useful in the diagnosis and tre- ment of lung cancer-both as it exists in the clinic and as it is being revoluti- ized in the laboratory. The book is intended to serve as a resource for researchers wishing to increase their knowledge of current and cutting edge technologies, in order that their investigations into neoplasms of the lung may benefit from this enriched diversity of techniques and approaches. Owing to the complex nature of the disease and the variety of methods available to analyze and attack it, no volume attempting to define diagnostic and therapeutic approaches to lung cancer can ever be complete. The sheer number of investigators involved in lung cancer research guarantees that some aspect will be inadvertently excluded. However, I hope that the range of techniques included herein will serve to open up new avenues of investigation for both the novice and experienced researcher.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Molecular and Genetic Aspects of Lung Cancer.- Detection of Altered Tumor Markers in Clinical Samples for Diagnosis and Prognosis.- Molecular Alterations in Lung Cancer.- Cellular Predictive Factors of Drug Resistance in Non-Small Cell Lung Carcinomas.- Clinical Implications of p53 Mutations in Lung Cancer.- An Epidemiologic and Clinicopathologic Overview of AIDS-Associated Pulmonary Kaposi's Sarcoma.- Myeloperoxidase Promoter Region Polymorphism and Lung Cancer Risk.- Clinical Utility of Tumor Markers in the Management of Non-Small Cell Lung Cancer.- Detection of Chromosomal Aberrations in Lung Tissue and Peripheral Blood Lymphocytes Using Interphase Fluorescence In Situ Hybridization (FISH).- In Situ Analysis of Telomerase RNA Gene Expression as a Marker for Tumor Progression.- A High-Throughput Methodology for Identifying Molecular Targets Overexpressed in Lung Cancers.- Expression Profiling of Lung Cancer Based on Suppression Subtraction Hybridization (SSH).- Comparative Genomic Hybridization of Human Lung Cancer.- Sensitive Assays for Detection of Lung Cancer.- Fluorescent Microsatellite Analysis in Bronchial Lavage as a Potential Diagnostic Tool for Lung Cancer.- Southern Blotting of Genomic DNA from Lung and Its Tumors.- Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity as Predictors of Lung Cancer Risk.- Comparative Multiplex PCR and Allele-Specific Expression Analysis in Human Lung Cancer.- Detection of K-ras Point Mutations in Sputum from Patients with Adenocarcinoma of the Lung by Point-EXACCT.- Detection of K-ras and p53 Mutations by "Mutant-Enriched" PCR-RFLP.- Detection of Small Cell Lung Cancer by RT-PCR for Neuropeptides, Neuropeptide Receptors, or a Splice Variant of the Neuron Restrictive Silencer Factor.- Utilization of ThyroidTranscription Factor-1 Immunostaining in the Diagnosis of Lung Tumors.- Molecular Biologic Substaging of Stage I NSCLC Through Immunohistochemistry Performed on Formalin-Fixed, Paraffin-Embedded Tissue.- A Sensitive Immunofluorescence Assay for Detection of p53 Protein in the Sputum.- SPR1.- Determination of Biological Parameters on Fine-Needle Aspirates from Non-Small Cell Lung Cancer.- Detection and Analysis of Lung Cancer Cells from Body Fluids Using a Rare Event Imaging System.- Reconstruction of Geno-Phenotypic Evolutionary Sequences from Intracellular Patterns of Molecular Abnormalities in Human Solid Tumors.- Novel Therapies.- Surgical Treatment of Lung Cancer.- Recent Advances and Dilemmas in the Radiotherapeutic Management of Locally Advanced Non-Small Cell Lung Cancer.- Photodynamic Therapy in Lung Cancer.- Gene Therapy for Lung Cancer.- Identifying Obstacles to Viral Gene Therapy for Lung Cancer.- Topical Gene Therapy for Pulmonary Diseases with PEI-DNA Aerosol Complexes.- Targeted Delivery of Expression Plasmids to the Lung via Macroaggregated Polyethylenimine-Albumin Conjugates.- Preparation of Retroviral Vectors for Cell-Cycle-Targeted Gene Therapy of Lung Cancer.- Aerosol Gene Therapy for Metastatic Lung Cancer Using PEI-p53 Complexes.- Clinical Development of Antisense Oligonucleotides as Anti-Cancer Therapeutics.- Antisense Oligonucleotides Targeting RI? Subunit of Protein Kinase A.- Use of Antisense Oligonucleotides for Therapy.- Induction of Programmed Cell Death with an Antisense Bcl-2 Oligonucleotide.- Tumor Vaccination with Cytokine-Encapsulated Microspheres.- Adoptive Immunotherapy.- Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Murine Lung Cancer Models.- Cyclooxygenase 2-Dependent Regulation of Antitumor Immunity in LungCancer.- Chemoprevention of Lung Cancer.- Assessing the Interaction of Particulate Delivery Systems with Lung Surfactant.- Chemopreventive Therapeutics.
Molecular and Genetic Aspects of Lung Cancer.- Detection of Altered Tumor Markers in Clinical Samples for Diagnosis and Prognosis.- Molecular Alterations in Lung Cancer.- Cellular Predictive Factors of Drug Resistance in Non-Small Cell Lung Carcinomas.- Clinical Implications of p53 Mutations in Lung Cancer.- An Epidemiologic and Clinicopathologic Overview of AIDS-Associated Pulmonary Kaposi's Sarcoma.- Myeloperoxidase Promoter Region Polymorphism and Lung Cancer Risk.- Clinical Utility of Tumor Markers in the Management of Non-Small Cell Lung Cancer.- Detection of Chromosomal Aberrations in Lung Tissue and Peripheral Blood Lymphocytes Using Interphase Fluorescence In Situ Hybridization (FISH).- In Situ Analysis of Telomerase RNA Gene Expression as a Marker for Tumor Progression.- A High-Throughput Methodology for Identifying Molecular Targets Overexpressed in Lung Cancers.- Expression Profiling of Lung Cancer Based on Suppression Subtraction Hybridization (SSH).- Comparative Genomic Hybridization of Human Lung Cancer.- Sensitive Assays for Detection of Lung Cancer.- Fluorescent Microsatellite Analysis in Bronchial Lavage as a Potential Diagnostic Tool for Lung Cancer.- Southern Blotting of Genomic DNA from Lung and Its Tumors.- Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity as Predictors of Lung Cancer Risk.- Comparative Multiplex PCR and Allele-Specific Expression Analysis in Human Lung Cancer.- Detection of K-ras Point Mutations in Sputum from Patients with Adenocarcinoma of the Lung by Point-EXACCT.- Detection of K-ras and p53 Mutations by "Mutant-Enriched" PCR-RFLP.- Detection of Small Cell Lung Cancer by RT-PCR for Neuropeptides, Neuropeptide Receptors, or a Splice Variant of the Neuron Restrictive Silencer Factor.- Utilization of ThyroidTranscription Factor-1 Immunostaining in the Diagnosis of Lung Tumors.- Molecular Biologic Substaging of Stage I NSCLC Through Immunohistochemistry Performed on Formalin-Fixed, Paraffin-Embedded Tissue.- A Sensitive Immunofluorescence Assay for Detection of p53 Protein in the Sputum.- SPR1.- Determination of Biological Parameters on Fine-Needle Aspirates from Non-Small Cell Lung Cancer.- Detection and Analysis of Lung Cancer Cells from Body Fluids Using a Rare Event Imaging System.- Reconstruction of Geno-Phenotypic Evolutionary Sequences from Intracellular Patterns of Molecular Abnormalities in Human Solid Tumors.- Novel Therapies.- Surgical Treatment of Lung Cancer.- Recent Advances and Dilemmas in the Radiotherapeutic Management of Locally Advanced Non-Small Cell Lung Cancer.- Photodynamic Therapy in Lung Cancer.- Gene Therapy for Lung Cancer.- Identifying Obstacles to Viral Gene Therapy for Lung Cancer.- Topical Gene Therapy for Pulmonary Diseases with PEI-DNA Aerosol Complexes.- Targeted Delivery of Expression Plasmids to the Lung via Macroaggregated Polyethylenimine-Albumin Conjugates.- Preparation of Retroviral Vectors for Cell-Cycle-Targeted Gene Therapy of Lung Cancer.- Aerosol Gene Therapy for Metastatic Lung Cancer Using PEI-p53 Complexes.- Clinical Development of Antisense Oligonucleotides as Anti-Cancer Therapeutics.- Antisense Oligonucleotides Targeting RI? Subunit of Protein Kinase A.- Use of Antisense Oligonucleotides for Therapy.- Induction of Programmed Cell Death with an Antisense Bcl-2 Oligonucleotide.- Tumor Vaccination with Cytokine-Encapsulated Microspheres.- Adoptive Immunotherapy.- Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Murine Lung Cancer Models.- Cyclooxygenase 2-Dependent Regulation of Antitumor Immunity in LungCancer.- Chemoprevention of Lung Cancer.- Assessing the Interaction of Particulate Delivery Systems with Lung Surfactant.- Chemopreventive Therapeutics.
Rezensionen
"This is a good compilation of scientific information on lung cancer...it serves as a useful resource for scientists involved in lung cancer." -Doody's Health Sciences Book Review Journal
"The strongest part of the book is the detailed description of the different molecular techniques for marker analyses, which will be of great value for the lung cancer scientists working in basic science ant translational lung cancer research." -Annals of Oncology
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
